Claim Missing Document
Check
Articles

Found 2 Documents
Search

Neuroimaging Findings in Patients with Covid-19 in Indonesia Sadikin, Cindy; Meryana, Meryana; Besin, Valentinus; Saelan, Yanna
Medica Hospitalia : Journal of Clinical Medicine Vol. 8 No. 1 (2021): Med Hosp
Publisher : RSUP Dr. Kariadi

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (380.59 KB) | DOI: 10.36408/mhjcm.v8i1.509

Abstract

Background: Covid-19 caused by the SARS-CoV-2 virus has spread worldwide, including Indonesia. Neurological manifestations has also been reported in Covid-19 positive patients. Yet documentation of their neuroimaging findings are lacking, especially in Indonesia. Objective: To understand neuroimaging findings in Covid-19 positive patients Methods: An observational study from medical record of Covid-19 positive patients in our hospital who developed abnormal neurologic manifestations and were followed up by neuroimaging examination from May to August 2020. Covid-19 positive diagnosis was confirmed from nasopharyngeal swab using the Real Time Polymerase Chain Reaction (RT-PCR). Neurological examination was performed by a neurologist, who then referred patients for neuroimaging examination using CT or MRI. Radiological expertise was performed by a radiologist. Results: A total of 288 patients who are Covid-19 positive from nasopharyngeal RT-PCR swab admitted to our hospital from May to August 2020. Ten patients (3.5%) had abnormal neurologic manifestations and further neuroimaging examination follow up. Range of age 33-72 years old and slight male predominance (60%). Frequent clinical symptoms were decreased consciousness (40%), altered mental status (30%) and tremors (20%). Neuroimaging findings were large vessel occlusion (30%), vasculitis (20%), post hipoxic leucoencephalopathy (10%), basal ganglia encephalopathy (10%), non specific small vessel ischemia changes and negative findings (30%). Most patients were discharged with clinical improvement (60%), while 40% mortality rate were seen in patient with large vessel occlusion (30%) and vasculitis (10%). Conclusion: Neuroimaging findings in Covid-19 positive patients were large vessel occlusion (LVO), vasculitis, post hipoxic leucoencephalopathy and basal ganglia encephalopathy Keywords: Covid-19, neurological, manifestation, neuroimaging
Peran Probiotik Terhadap Perbaikan Gejala Motorik Pada Pasien Dengan Penyakit Parkinson: Sebuah Meta-Analisis Erwin, Ferdinand; Meryana, Meryana; Kurniawati, Nita; Kartikasari, Desy; Supit, Paulus A
Journal of Medicine and Health Vol 6 No 2 (2024)
Publisher : Universitas Kristen Maranatha

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.28932/jmh.v6i2.8805

Abstract

Penyakit Parkinson merupakan penyakit neurodegeneratif paling sering diderita kedua setelah penyakit Alzheimer, yang ditandai dengan adanya bradikinesia, tremor saat istirahat, dan rigiditas. Penanda utama dari penyakit Parkinson adalah patologi α-synuclein yang disebut dengan Lewy Body. Beberapa penelitian terbaru menunjukkan peran gut dysbiosis menjadi salah satu faktor dalam patofisiologi penyakit Parkinson. Beberapa penelitan sebelumnya menunjukkan efektivitas probiotik terhadap perbaikan klinis penyakit Parkinson. Tujuan dari penelitian ini adalah untuk menganalisis peran probiotik terhadap gejala motorik pasien dengan penyakit Parkinson. Metode penelitian ini adalah dengan melakukan pencarian studi melalui berbagai database seperti Pubmed, Scopus, Cochrane, dan ProQuest. Studi yang didapatkan kemudian dilakukan skrining, penilaian kualitas studi, dan analisis kuantitatif. Hasil penelitian ini didapatkan total 5 studi yang melibatkan 339 pasien dengan penyakit Parkinson. Meta-analisis penelitian ini menunjukkan penurunan skor Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III) secara signifikan (standardized mean difference: -0,25; interval kepercayaan 95%, -0,44 hingga -0,06) pada pasien dengan penyakit Parkinson setelah pemberian probiotik. Penelitian ini menunjukkan bahwa probiotik dapat memperbaiki gejala motorik secara signifikan pada pasien dengan penyakit Parkinson yang diukur dengan skala UPDRS-III, serta relatif aman dan dapat ditoleransi dengan baik.